This is an audio transcript of the FT News Briefing podcast episode: ‘Big Pharma markets left in a ‘patent cliff’-hanger’ ...

Thousands of customers are set to receive payments after purchasing a weight loss supplement once described as the “Gastric Bypass Alternative,” according to the FTC.

The Trump administration's antitrust enforcers have demonstrated a willingness to clear multibillion-dollar deals, marking a shift from the Biden administration.